[1] De Pauw B, Walsh TJ,Donnelly JP,et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group[J].Clin Infect Dis, 2008, 46(12): 1813-1821. [2] 李铁男. 天疱疮和大疱性类天疱疮患者口腔念珠菌感染的调查研究[J].中国真菌学杂志,2007,2(5):284-285. [3] Agusti C, Rano A, Filella X, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment-etiology, prognostic factors, and associated inflammatory response[J]. CHEST,2003,123(2):488-498. [4] Rhen T,Cidlowski JA.Antiinflammatory action of glucocorticoids—new mechanisms for old drugs[J].N Engl J Med,2005,353(16):1711-1723. [5] Lionakis MS,Kontoyiannis DP.Glucocorticoids and invasive fungal infections[J].Lancet,2003,362(9398):1828-1838. [6] Ng TT,Robson GD,Denning DW.Hydrocortisone-enhanced growth of Aspergillus spp.:implications for pathogenesis[J].Microbiology,1994,140(9):2475-2479. [7] Verweij PE, Varga J, Houbraken J, et al. Emericella quadrilineata as cause of nvasive aspergillosis[J].Emerg Infect Dis,2008,14(4):566-572. [8] Roilides E, Lyman CA, Filioti J, et al. Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus [J]. Antimicrob Agents Chemother, 2002, 46(6): 1974-1976. [9] Helmick RA, Fletcher AE, Gardner AM, et al. Imidazole antibiotics inhibit the nitric oxide dioxygenase function of microbial flavohemoglobin[J]. Antimicrob Agents Chemother, 2005,49(5): 1837-1843. [10] Chiller T, Farrokhshad K, Brummer E, et al. The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus [J]. Diagn Microbiol Infect Dis, 2001, 39(2): 99-103. |